Universe Pharmaceuticals INC (UPC) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Universe Pharmaceuticals INC (UPC) Bundle
Simplify Universe Pharmaceuticals INC (UPC) valuation with this customizable DCF Calculator! Featuring real Universe Pharmaceuticals INC (UPC) financials and adjustable forecast inputs, you can test scenarios and uncover Universe Pharmaceuticals INC (UPC) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33.2 | 30.7 | 48.0 | 40.1 | 32.3 | 33.3 | 34.4 | 35.5 | 36.7 | 37.8 |
| Revenue Growth, % | 0 | -7.6 | 56.27 | -16.34 | -19.52 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 |
| EBITDA | 10.2 | 10.6 | 14.2 | -7.3 | -3.2 | 4.4 | 4.6 | 4.7 | 4.9 | 5.0 |
| EBITDA, % | 30.62 | 34.56 | 29.59 | -18.25 | -9.95 | 13.31 | 13.31 | 13.31 | 13.31 | 13.31 |
| Depreciation | .4 | .4 | .4 | .5 | .5 | .4 | .4 | .5 | .5 | .5 |
| Depreciation, % | 1.26 | 1.34 | 0.93134 | 1.33 | 1.57 | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 |
| EBIT | 9.8 | 10.2 | 13.7 | -7.9 | -3.7 | 4.0 | 4.1 | 4.3 | 4.4 | 4.5 |
| EBIT, % | 29.36 | 33.23 | 28.66 | -19.58 | -11.53 | 12.03 | 12.03 | 12.03 | 12.03 | 12.03 |
| Total Cash | 3.2 | 10.1 | 21.8 | 18.9 | 18.5 | 12.8 | 13.2 | 13.6 | 14.1 | 14.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6.4 | 10.9 | 15.8 | 15.2 | 10.7 | 10.6 | 10.9 | 11.3 | 11.6 | 12.0 |
| Account Receivables, % | 19.32 | 35.41 | 32.95 | 37.82 | 33.21 | 31.74 | 31.74 | 31.74 | 31.74 | 31.74 |
| Inventories | 2.6 | 1.9 | 2.5 | 2.2 | 3.3 | 2.3 | 2.4 | 2.5 | 2.6 | 2.7 |
| Inventories, % | 7.87 | 6.21 | 5.13 | 5.5 | 10.35 | 7.01 | 7.01 | 7.01 | 7.01 | 7.01 |
| Accounts Payable | 1.9 | 2.7 | 5.3 | 3.1 | 4.6 | 3.2 | 3.3 | 3.4 | 3.5 | 3.6 |
| Accounts Payable, % | 5.83 | 8.76 | 11.07 | 7.66 | 14.19 | 9.5 | 9.5 | 9.5 | 9.5 | 9.5 |
| Capital Expenditure | -.1 | -.1 | -13.5 | -.1 | .0 | -1.9 | -2.0 | -2.1 | -2.1 | -2.2 |
| Capital Expenditure, % | -0.25978 | -0.1687 | -28.2 | -0.23342 | -0.13672 | -5.8 | -5.8 | -5.8 | -5.8 | -5.8 |
| Tax Rate, % | -60.1 | -60.1 | -60.1 | -60.1 | -60.1 | -60.1 | -60.1 | -60.1 | -60.1 | -60.1 |
| EBITAT | 7.6 | 7.6 | 11.4 | -8.6 | -6.0 | 3.5 | 3.6 | 3.7 | 3.8 | 4.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | .9 | 5.0 | -4.6 | -9.5 | -.7 | 1.7 | 1.7 | 1.8 | 1.9 | 1.9 |
| WACC, % | 5.89 | 5.78 | 6.03 | 6.57 | 6.57 | 6.17 | 6.17 | 6.17 | 6.17 | 6.17 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 7.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 2 | |||||||||
| Terminal Value | 47 | |||||||||
| Present Terminal Value | 35 | |||||||||
| Enterprise Value | 42 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | 42 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | 11.61 |
What You Will Receive
- Pre-Filled Financial Model: Universe Pharmaceuticals INC's (UPC) actual data facilitates accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential metrics.
- Real-Time Calculations: Automatic updates provide immediate results as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
- Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Universe Pharmaceuticals INC (UPC).
- WACC Calculator: Ready-to-use Weighted Average Cost of Capital sheet with adjustable inputs specific to UPC.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit UPC's projections.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Universe Pharmaceuticals INC (UPC).
- Interactive Dashboard and Charts: Visual representations of key valuation metrics for streamlined analysis of UPC.
How It Works
- Download: Obtain the pre-formatted Excel file containing Universe Pharmaceuticals INC's (UPC) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC as needed.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various forecasts and evaluate outcomes instantly.
- Make Decisions: Leverage the valuation results to inform your investment strategy.
Why Choose the UPC Calculator?
- Accuracy: Utilizes real Universe Pharmaceuticals INC (UPC) financial data for precise results.
- Flexibility: Tailored for users to easily adjust and experiment with inputs.
- Time-Saving: Eliminate the need to construct a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
- User-Friendly: Simple to navigate, even for those lacking advanced financial modeling skills.
Who Should Use This Product?
- Investors: Assess Universe Pharmaceuticals INC’s (UPC) valuation prior to making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and evaluate financial forecasts.
- Startup Founders: Understand the valuation strategies of established pharmaceutical companies like Universe Pharmaceuticals INC (UPC).
- Consultants: Provide clients with detailed and professional valuation assessments.
- Students and Educators: Utilize real-time data from Universe Pharmaceuticals INC (UPC) to enhance learning of valuation methods.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Universe Pharmaceuticals INC (UPC) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), featuring parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showcasing intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to facilitate analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Universe Pharmaceuticals INC (UPC).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions for easy result analysis.